The emerging roles of YAP and TAZ in cancer

Toshiro Moroishi1, Carsten Gram Hansen1, Kun-Liang Guan1

  • 1Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA.

Nature Reviews. Cancer
|January 17, 2015
PubMed

Insights

The Hippo pathway

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Hippo pathway is crucial for regulating tissue homeostasis and organ size.
  • Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are key downstream effectors of this pathway.
  • Dysregulation of YAP and TAZ is implicated in various cancers.

Purpose of the Study:

  • To summarize the biological functions of YAP and TAZ.
  • To elucidate how YAP and TAZ regulation is disrupted in cancer.
  • To highlight the therapeutic potential of targeting YAP and TAZ in cancer treatment.

Main Methods:

  • Literature review of current research on YAP and TAZ.
  • Analysis of the role of YAP and TAZ in cancer progression.
  • Evaluation of YAP and TAZ as therapeutic targets.

Main Results:

  • YAP and TAZ play significant roles in tissue homeostasis, organ size, regeneration, and tumorigenesis.
  • Disrupted regulation of YAP and TAZ is a common feature in cancer development.
  • Emerging evidence points to the expanding role of YAP and TAZ in driving cancer progression.

Conclusions:

  • YAP and TAZ are critical regulators with implications in cancer biology.
  • Targeting YAP and TAZ presents a promising avenue for novel cancer therapies.
  • Further research is needed to fully exploit their therapeutic potential.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K